(Q33892956)

29 July 2017

title

Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis (English)

1 reference

cost-effectiveness analysis

29 July 2017

0 references

0 references

1 reference

Schwartzman K

1

1 reference

29 July 2017

Menzies D

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

American Journal of Respiratory and Critical Care Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

161

1 reference

29 July 2017

issue

3 Pt 1

1 reference

29 July 2017

page(s)

780-789

1 reference

Tuberculosis in a Cohort of Southeast Asian Refugees: A Five-Year Surveillance Study

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Results of screening for tuberculosis in foreign-born persons applying for adjustment of immigration status

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Mathematical model for the epidemiology of tuberculosis, with estimates of the reproductive number and infection-delay function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Chest roentgenogram in pulmonary tuberculosis. New data on an old test

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

The incidence of false-positive cultures for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Tuberculin and Anergy Testing in HIV-Seropositive and HIV-Seronegative Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

School-based screening for tuberculous infection. A cost-benefit analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Frequency and type of reactions to antituberculosis drugs: observations in routine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

Risk Factors for Tuberculosis in HIV-lnfected Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.161.3.9902005

10.1164/AJRCCM.161.3.9902005

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference